Simplify your study design and gain clearer insights with preconfigured panels of patient‑derived organoids that preserve tumor heterogeneity and are supported by rich genomic, drug response, and clinical metadata—enabling consistent, side‑by‑side comparisons grounded in real biology. Designed for predictive relevance at key decision points, these panels help you determine when to move beyond standard models and generate more confident, defensible translational results—while reducing variability and accelerating workflows.